초록 ▼

An implantable coaxial lead includes a cable with male and female connectors. The cable includes inner and outer helical coils separated by an inner insulator tube, with an outer insulator tube surrounding the outer helical coil. The male connector includes an outer conductive cylinder, a conductive

An implantable coaxial lead includes a cable with male and female connectors. The cable includes inner and outer helical coils separated by an inner insulator tube, with an outer insulator tube surrounding the outer helical coil. The male connector includes an outer conductive cylinder, a conductive pin and an insulator molded in between. For increased strength, a braided cylinder, infused with rubber, is included at the juncture of the male connector and the cable. The female connector includes a cylinder formed by two conducting body elements and an intervening insulating body element. The female connector includes respective conductive tension elements configured to engage the male connector. A first seal is provided between the conductive tension members for electrical isolation and tactile feedback. An insertion tool includes a cylinder with a hollow bore and detachable head, and a rod for pulling the lead through the cylinder.

대표청구항 ▼

An implantable coaxial lead includes a cable with male and female connectors. The cable includes inner and outer helical coils separated by an inner insulator tube, with an outer insulator tube surrounding the outer helical coil. The male connector includes an outer conductive cylinder, a conductive

An implantable coaxial lead includes a cable with male and female connectors. The cable includes inner and outer helical coils separated by an inner insulator tube, with an outer insulator tube surrounding the outer helical coil. The male connector includes an outer conductive cylinder, a conductive pin and an insulator molded in between. For increased strength, a braided cylinder, infused with rubber, is included at the juncture of the male connector and the cable. The female connector includes a cylinder formed by two conducting body elements and an intervening insulating body element. The female connector includes respective conductive tension elements configured to engage the male connector. A first seal is provided between the conductive tension members for electrical isolation and tactile feedback. An insertion tool includes a cylinder with a hollow bore and detachable head, and a rod for pulling the lead through the cylinder. ch the indicator includes an amplitude. 15. The method of claim 13, in which the indicator includes a pulsewidth. 16. The method of claim 13, further including displaying, on a user interface screen, the electrogram, the markers of stimulated and sensed events, and the indicator of the energy of each of the stimulated event markers. 17. The method of claim 16, further including enlarging a portion of the display on the user interface screen. 18. The method of claim 13, further including storing, on a storage medium, the electrogram, the markers of stimulated and sensed events, and the indicator of the energy of each of the stimulated event markers. 19. A cardiac rhythm management system including: an external user interface, the user interface including a communication module, adapted for remote communicative coupling to an implantable device; a recorded output indicator of energy associated with an instance of therapy delivery by the implantable device; a therapy marker associated with an instance of therapy delivery by the implantable device; a representation of a cardiac signal acquired by the implantable device; in which at least one of the output indicator of energy and the therapy marker is associated with each instance of therapy delivery by the implantable device; a printer adapted to print at least one of the output indicator of energy, the therapy marker, and the representation of the cardiac signal; an implantable cardiac rhythm management device adapted for communicative coupling to the user interface; and a leadwire adapted for coupling the cardiac rhythm management device to a patient. 20. A cardiac rhythm management system including: an external user interface, the user interface including a communication module, adapted for remote communicative coupling to an implantable device; a recorded output indicator of energy associated with an instance of therapy delivery by the implantable device; a therapy marker associated with an instance of therapy delivery by the implantable device; a representation of a cardiac signal acquired by the implantable device; in which at least one of the output indicator of energy and the therapy marker is associated with each instance of therapy delivery by the implantable device; and a user interface screen adapted to display at least one of the output indicator of energy, the therapy marker, and the representation of the cardiac signal, wherein a portion of the display on the user interface screen is enlarged. 21. A method including: delivering electrical stimulation pulses to a patient; and recording an indicator of energy associated with each pulse, in which the recording includes printing a strip chart including an electrogram, markers of stimulated and sensed events, and an indicator of the energy associated with each of the stimulated event markers, and in which the indicator includes a pulsewidth. 22. A method including: delivering electrical stimulation pulses to a patient; and recording an indicator of energy associated with each pulse, in which the recording includes printing a strip chart including an electrogram, markers of stimulated and sensed events, and an indicator of the energy associated with each of the stimulated event markers; and displaying, on a user interface screen, the electrogram, the markers of stimulated and sensed events, and the indicator of the energy of each of the stimulated event markers, and further including enlarging a portion of the display on the user interface screen. 23. A cardiac rhythm management system including: a user interface, the user interface including a communication module adapted for communicating to an implantable device; and an alphanumeric indicator of pacing-level energy associated with an instance of pacing-level therapy delivery by the implantable device. 24. The system of claim 23, further including a therapy marker associated with the instance of the pacing-level therapy delivery by the implantable device. 25. The system of claim 24, in which at least one of the output indicator of energy and the therapy marker is associated with each instance of therapy delivery by the implantable device. 26. The system of claim 23, further including a representation of a cardiac signal acquired by the implantable device. 27. The system of claim 23, further including a printer adapted to print the alphanumeric indicator of pacing-level energy in association with at least one of a therapy marker and a representation of a cardiac signal. 28. The system of claim 23, further including an implantable cardiac rhythm management device adapted for communicative coupling to the user interface. 29. The system of claim 28, further including a leadwire adapted for coupling the cardiac rhythm management device to a subject. 30. The system of claim 23, further including a user interface screen adapted to display the alphanumeric indicator of pacing-level energy in association with at least one of a therapy marker and a representation of a cardiac signal. 31. The system of claim 30, in which a portion of the display on the user interface screen is enlarged. 32. The system of claim 23, further including a storage medium adapted to store the indicator of pacing-level energy. 33. A cardiac rhythm management system including: a remote user interface, the user interface including a telemetry module, adapted for communicative coupling to an implantable device; and at least one of: a printer adapted to provide a printout including an electrogram, markers of paced and sensed events, and a separate alphanumeric indicator of energy associated with each of the paced markers. a user interface screen adapted to display at least one of the electrogram, the markers of paced and sensed events, and the separate alphanumeric indicator of energy associated with each of the paced markers. a storage medium adapted to store at least one of the electrogram, the markers of paced and sensed events, and the alphanumeric separate indicator of energy associated with each of the paced markers. 34. A method including: delivering electrical pacing stimulation pulses to a patient; and recording an alphanumeric indicator of pacing energy associated with each pulse. 35. The method of claim 34, in which the recording includes printing a strip chart including an electrogram, markers of stimulated and sensed events, and an alphanumeric indicator of the energy associated with each of the stimulated event markers. 36. The method of claim 34, in which the alphanumeric indicator indicates an amplitude. 37. The method of claim 34, in which the alphanumeric indicator indicates a pulsewidth. 38. The method of claim 34, further including displaying, on a user interface screen, the alphanumeric indicator of pacing energy. 39. The method of claim 34, further including storing, on a storage medium, the alphanumeric indicator of pacing energy. p consisting of: breast tissue, uterine tissue, cervical tissue, intestinal tissue, colorectal tissue, esophageal tissue, skin, prostate tissue, lymph tissue, bone, and brain tissue. 18. The method of claim 1, comprising topically administering the contrast enhancing agent. 19. The method of claim 18, wherein the contrast agent is selected from the group consisting of: iodine and weak acids and bases. 20. The method of claim 1, comprising administering the contrast enhancing agent intravenously, subcutaneously, intraperitonally, or intraarterially. 21. The method of claim 1, wherein the control data set represents one or more optical properties of a plurality of spatially resolved areas within a control area of interest believed to contain normal tissue of the same tissue type as the area of interest. 22. The method of claim 1, comprising acquiring a plurality of data sets representing one or more optical properties of spatially resolved areas within the area of interest at preselected time intervals subsequent to administration of the contrast enhancing agent. 23. The method of claim 1, wherein the area of interest is an area of the patient believed to contain cancerous tissue, and the control data set is derived from a different area of the patient believed to contain normal tissue. 24. The method of claim 1, wherein the control data set represents one or more corresponding optical properties empirically determined to be indicative of normal tissue. 25. The method of claim 1, wherein the control data set represents one or more corresponding optical properties empirically determined to be indicative of an identified type of cancerous tissue. 26. The method of claim 1 for spatially locating cancerous tissue in an area of interest prior to removing a tissue sample. 27. The method of claim 1 for monitoring the progression or recession of cancerous tissue in the patient. 28. The method of claim 1, wherein the illuminating of the area of interest is by short pulse or pulse time illumination. 29. The method of claim 1, wherein the illuminating separates out optical properties. 30. The method of claim 1, comprising producing a comparison data set by the differences in optical properties and displaying the comparison data set as a three dimensional image. 31. The method of claim 1, comprising producing a comparison data set by the differences in optical properties at each of two or more wavelengths of emr. 32. The method of claim 1, further comprising producing a comparison data set by differences in the optical properties and processing the comparison data set to provide an enhanced contrast color image. 33. A method for in situ grading and characterizing a cancerous tissue in a patient, comprising: positioning one or more illumination source and detector arrays in contact with the patient; illuminating an area of interest lying under an exterior surface with the illumination source array(s) emitting electromagnetic